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Flavin-containing Baeyer–Villiger monooxygenases employ
NADPH and molecular oxygen to catalyze the insertion of an
oxygen atom into a carbon–carbon bond of a carbonylic substrate.
These enzymes can potentially be exploited in a variety of bio-
catalytic applications given the wide use of Baeyer–Villiger reac-
tions in synthetic organic chemistry. The catalytic activity of these
enzymes involves the formation of two crucial intermediates: a
flavin peroxide generated by the reaction of the reduced flavin
with molecular oxygen and the ‘‘Criegee’’ intermediate resulting
from the attack of the flavin peroxide onto the substrate that is
being oxygenated. The crystal structure of phenylacetone mono-
oxygenase, a Baeyer–Villiger monooxygenase from the thermo-
philic bacterium Thermobifida fusca, exhibits a two-domain archi-
tecture resembling that of the disulfide oxidoreductases. The
active site is located in a cleft at the domain interface. An arginine
residue lays above the flavin ring in a position suited to stabilize
the negatively charged flavin-peroxide and Criegee intermediates.
This amino acid residue is predicted to exist in two positions; the
‘‘IN’’ position found in the crystal structure and an ‘‘OUT’’ position
that allows NADPH to approach the flavin to reduce the cofactor.
Domain rotations are proposed to bring about the conformational
changes involved in catalysis. The structural studies highlight the
functional complexity of this class of flavoenzymes, which coor-
dinate the binding of three substrates (molecular oxygen, NADPH,
and phenylacetone) in proximity of the flavin cofactor with for-
mation of two distinct catalytic intermediates.
flavoenzyme  mechanism of catalysis  biocatalysis  Baeyer–Villiger
reaction  crystallography
A t the end of the 19th century, Baeyer and Villiger (1)discovered that cyclic ketones react with oxidants, such as
peroxymonosulfuric acid, to yield lactones. The mechanism of
the Baeyer–Villiger reaction involves a nucleophilic attack of a
peroxide to the ketone reagent to generate the so-called ‘‘Cr-
iegee’’ intermediate (Fig. 1), which is followed by an intramo-
lecular rearrangement that leads to the migration of an alkyl
group to an oxygen atom, generating the lactone product.
Baeyer–Villiger reactions are of enormous value in synthetic
organic chemistry, and the number of their applications is
countless.
Several microorganisms produce enzymes capable to catalyze
Baeyer–Villiger reactions. These proteins are extensively studied
for their exploitation in biocatalytic applications (2, 3). This
interest follows the problems related to the toxicity and insta-
bility of the oxidizing reactants that are currently being used in
chemical processes. In addition, enzymatic reactions exhibit a
superior degree of enantio- and regioselectivity. Baeyer–Villiger
monooxygenases are classified depending on the nature of their
f lavin cofactor (4). The type I enzymes are the most extensively
investigated (5). They are FAD-dependent proteins that use
NADPH and molecular oxygen to insert an oxygen atom into
their substrate. Kinetic and spectroscopic data have shown that
the mechanism underlying the enzyme reaction is conceptually
identical to that of the equivalent nonenzymatic processes (6).
The key feature is the reaction of the NADPH-reduced flavin
with molecular oxygen to generate a stable flavin-peroxide
intermediate, which attacks the carbonyl carbon of the substrate
(Fig. 1). Rearrangement of the resulting Criegee intermediate
yields the oxygenated product and a hydroxy-f lavin adduct,
which must be hydrolyzed to regenerate the oxidized flavin.
Oxidized NADP remains tightly bound throughout the catalytic
process and does not dissociate before decay of the flavin-
peroxide intermediate (Fig. 1) (7).
Here, we describe the three-dimensional structure of a Baeyer–
Villiger monooxygenase. We have expressed and purified several
monooxygenases (2, 8), and the only protein that so far produced
crystals suited for x-ray analysis is phenylacetone monooxygen-
ase (PAMO) from the moderate thermophilic bacterium Ther-
mobifida fusca. PAMO is a monomeric 62-kDa enzyme that
catalyses the conversion of phenylacetone to phenylacetate (Fig.
1) and displays high homology to other well characterized type
I Baeyer–Villiger monooxygenases (Fig. 2).
Materials and Methods
Protein Expression, Purification, and Crystallization. The pamo gene
from genomic DNA of T. fusca was cloned in a pBAD (Invitro-
gen) expression vector. Transformed Escherichia coli TOP10
cells were grown at 37°C in Terrific Broth medium supplemented
with 100 gml ampicillin and 0.1% (wtvol) arabinose. To
obtain the selenomethionine-substituted PAMO, transformed
BL21(DE3)RP cells were grown in a minimal M9 medium (64
g/liter dibasic sodium phosphate15 g/liter monobasic potassium
phosphate2.5 g/liter sodium chloride5 g/liter ammonium chlo-
ride) supplemented with Lys, Thr, Phe, Leu, Ile, Val, Pro, and
L-selenomethionine (100 mg of amino acid per liter)2 mM
magnesium sulfate0.1 mM calcium chloride1 mM thia-
mine1% (vol/vol) glycerol100 g/ml ampicillin.
E. coli cells were harvested by centrifugation and resuspended
in 50 mM sodium phosphate buffer5 mM 2-mercaptoetha-
nol35 g/ml DNase1 mM PMSF, pH 7.0. The cell extract was
centrifuged and then incubated for 1 h at 50°C. We added 1.5 M
ammonium sulfate to the supernatant, which was then loaded
onto a butyl-Sepharose column (1610) preequilibrated with 50
mM sodium phosphate1.5 M ammonium sulfate, pH 7.0.
PAMO was eluted with a descending gradient of 1.5–0.7 M
ammonium sulfate and dialyzed against 50 mM sodium phos-
phate buffer, pH 7.0. The dialyzed sample was loaded onto a
preparative Superdex 200 (1660) column preequilibrated with
the same buffer. Pooled fractions were loaded onto a Mono Q
HR 55 column and eluted with a linear ascending gradient of
0–1 M NaCl. During the purification procedures, the protein lost
the FAD cofactor. Therefore, an excess of FAD (5 mM) was
added to the final protein sample by incubation at 50°C for 1 h.
The purification of selenomethionine-substituted PAMO was
performed with the same protocol used for native protein,
except for the addition of 5 mM DTT.
Crystals of PAMO were grown at 293 K by the vapor diffusion
method. Hanging drops were formed by mixing equal volumes of
18 mg of protein per ml in 5 mM FAD and 50 mM sodium
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phosphate, pH 7.0, and of a well solution consisting of 1.5 M
ammonium sulfate and 0.5 M lithium chloride.
Structure Determination. PAMO crystals belong to space group
I222. The asymmetric unit contains a PAMO monomer with a
solvent content of 63%. Diffraction data were measured at 100
K on Beamlines BM14 and ID14-EH1 of the European Syn-
chrotron Radiation Facility (Grenoble, France). The data sets
were processed (Table 1) by using MOSFLM (9) and the CCP4 suite
of programs (10).
The structure of PAMO was solved by using the single-
wavelength anomalous dispersion method. The six selenium sites
were found by using SHELXD (11). Phasing with the program
SHARP (12) produced an electron density map of good quality.
The program WARP (13) was used to automatically build 470 of
542 residues. The subsequent refinement was carried out by
using the native 1.7-Å-resolution data with REFMAC (14). Model
building was done with the program O (15). The refined model
has good stereochemical parameters (Table 2). The N-terminal
nine amino acids are disordered and not visible in the electron
density map.
Model analysis was carried out with DALI (16), PROCHECK (17),
O (15), and programs of the CCP4 package (10). Pictures were
generated with MOLSCRIPT (18), BOBSCRIPT (19), RASTER3D (20),
and ESPRIT (21).
Results
Overall Structure. PAMO consists of two domains (Fig. 3): the
FAD-binding domain (residues 10–158 and 390–542) and the
NADP-binding domain (residues 159–389). Both domains ex-
hibit the typical dinucleotide-binding fold (22). A search of the
Protein Data Bank (23) with the program DALI (16) showed that
PAMO has the highest structural similarity with the flavoprotein
class of the disulfide oxidoreductases (24). The closest structural
homologues of PAMO are NADH peroxidase (rms deviation of
3.8 Å for 278 C atoms with 18% sequence identity) (25) and
human glutathione reductase (rms deviation of 4.1 Å for 276 C
atoms with 14% sequence identity) (26). Comparison with the
disulfide oxidoreductases shows that the basic dinucleotide-
binding scaffold is conserved, although with some differences.
The FAD-binding domain of PAMO contains three C-terminal
-helices (Figs. 2 and 3) that are not present in the corresponding
domain of the disulfide oxidoreductases. In addition, the NADP-
binding domain of PAMO exhibits a large insertion of 120 aa
(residues 220–340) just after the  unit, which is at the heart
of the NADP-binding site. The inserted residues form a -helical
subdomain, which interacts with the FAD-binding domain,
forming part of the active site (Fig. 3). The subdomain residues
display rather poor sequence conservation (Fig. 2). A DALI (16)
search shows that there are no other three-dimensional protein
structures that have an inserted subdomain of this topology,
which seems, therefore, characteristic of the Baeyer–Villiger
monooxygenase class of enzymes (27, 28).
The FAD-Binding Site. The recombinant PAMO is purified mostly
in the apo form because the cofactor is lost during purification.
Incubation with FAD fully restores the enzymatic activity, and
the crystalline protein binds the cofactor with full occupancy
(see Fig. 5). The cofactor exhibits the same binding mode found
in flavoenzyme structures with similar topology (Fig. 3). The
Ade ring is partly solvent-accessible, whereas the remaining part
of the cofactor is fully embedded by the protein, establishing a
number of van der Waals and H-bond interactions.
The flavin ring binds at the bottom of the cleft between the
two domains of the protein (Fig. 3). The O2 and O4 atoms of the
flavin ring (the flavin atomic numbering is shown in Fig. 1) are
engaged in H-bonds with the backbone N atoms of Met-446 and
Asp-66 (Fig. 4). The N1 atom establishes an intramolecular
H-bond with the 3-OH group of the ribityl chain. No H-bonds
involve the N5 atom, which is at 3.5 and 3.7 Å from the N and
OD2 atoms of Asp-66, respectively. On the si side, the flavin
makes extensive van der Waals contacts with a cluster of
conserved aromatic amino acids (Trp-55, Tyr-60, and Tyr-72)
(Fig. 4). Conversely, the side chain of an Arg residue (Arg-337)
lays on the re side of the flavin ring (Figs. 4 and 5). Arg-337
exhibits a rather broad electron density. We have observed this
Fig. 1. Schematic representation of the overall catalytic reaction of the Baeyer–Villiger monooxygenases with reference to PAMO (mainly based on the kinetic
analysis by Sheng et al. (7) of cyclohexanone monooxygenase). The atomic numbering of the flavin ring is shown on the left (corresponding to the initial step
of the reaction).
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feature in all density maps calculated with the many data sets
that were measured in the course of the crystallographic analysis.
Based on these findings, Arg-337 has been modeled in a double
conformation (Figs. 4 and 5). This interpretation is corroborated
by the usage of the automated side-chain docking algorithm of
the program WARP (13), which identifies the two alternate
conformations as equally compatible with the electron density
map. The disorder is confined to the side-chain atoms because
the backbone atoms of Arg-337 and of its neighboring residues
are in well defined electron density and display B-factors that do
not differ from the average protein B-factor (Table 2).
The NADP-Binding Site. We have performed extensive cocrystal-
lization and soaking experiments with NADP, NADPH, and
their analogs. However, none of them was successful in that the
resulting crystals did not contain a bound ligand molecule as
gathered from the inspection of the electron density map. The
protein region forming the NADP-binding site can be inferred
from the comparison with the structures of the NAD(P)(H)
complexes of flavoenzymes with similar folding topology. We
have exploited the structures of human glutathione reductase
(complex with NADPH) (29), NADH peroxidase (complex with
NADH) (25) and E. coli thioredoxin reductase (complex with a
NADP analogue) (30). Based on the similarity with these
enzymes, NADP(H) is predicted to bind in an extended confor-
mation on the surface of the NADP-binding domain (Fig. 6). The
Ade-ribose moiety binds at the C terminus of the central -sheet
of the domain, whereas the nicotinamide ring points toward the
re side of the flavin ring at the domain interface. A key feature
of the proposed NADP binding mode is that the Ade ring binds
in a region involved in crystal-packing interactions. In particular,
residues 506–513 of a symmetry-related molecule form a long
protruding loop that occupies the Ade site. Such a steric
hindrance caused by crystal packing provides an explanation for
the failure of all soaking experiments.
Several observations support the proposed binding site of
NADP(H). The ligand pyrophosphate group is expected to bind
at the N terminus of the -helix 8 (Fig. 2) on the first  unit
of the NADP-binding domain. In the crystal structure, a sulfate
ion (Figs. 3 and 6) is present in this position, which, therefore,
appears to be able to bind a negatively charged group. In
Fig. 2. Sequence alignment of representative Baeyer–Villiger monooxygen-
ases. PAMO is from T. fusca (8); CPMO is cyclopentanone monooxygenase from
Comamonas testosteroni (34); CHMO is cyclohexanone monooxygenase from
Acinetobacter calcoaceticus (NCIMB catalog no. 9871) (35); HAPMO is 4-hy-
droxyacetophenone monooxygenase from Pseudomonas fluorescens (36).
The sequence alignment was calculated with CLUSTALW (37). The secondary
structure elements present in the PAMO three-dimensional structure are
numbered sequentially. The first 140 amino acids of 4-hydroxyacetophenone
monooxygenase are omitted because they form an additional domain nor-
mally not found in Baeyer–Villiger monooxygenases. Strictly conserved resi-
dues are shown in filled boxes.




No. of crystals 1 2
abc, Å 86.47115.65165.25 86.32117.01161.98
Resolution, Å 1.7 2.8
Rsym*† 0.10 (0.39) 0.16 (0.38)
Completeness,† % 96.2 (80.3) 99.9 (99.9)
I(I)† 8.5 (3.1) 16.9 (3.9)






Phasing power — 0.73
—, Not applicable.
*Rsym  hiI(hkl)  I(hkl)hiI(hkl).
†Data for the highest resolution shell are given in parentheses.
‡FOM, overall figure of merit calculated by the program SHARP (12).
Table 2. Refinement statistics
Resolution range, Å 15.0–1.7
Rfactor (Rfree)* 0.212 (0.243)
No. of non-hydrogen protein atoms 4,323
No. of water molecules 536





rmsd bond length,† Å 0.012
rmsd bond angle,† ° 1.25
Ramachandran plot‡
Most favorable region, % 92.4
Disallowed regions, % 0.00
*RfactorFobs FcalcFobs; Rfree is the Rfactor value for 5% of the reflections
excluded from the refinement.
†rms deviations (rmsd) from ideal values calculated with REFMAC (14).
‡Values are from PROCHECK (17).








4-hydroxyacetophenone monooxygenase (Fig. 2), replacement
of the residue corresponding to Arg-217 of PAMO with an Ala
side chain greatly reduces the affinity for NADPH (28). Con-
sistent with this finding, the three-dimensional structure reveals
that Arg-217 is an integral part of the binding site for the NADP
Ade moiety. The side chain of Lys-336 is close to the predicted
location of the 2-phosphate of NADP, and its amino group
appears to be properly positioned to establish a direct or
water-mediated H-bond with the NADP phosphate (Fig. 6). A
Lys3Ala mutation targeting the corresponding residue in 4-
hydroxyacetophenone monooxygenase causes a drastic reduc-
tion in the affinity for NADPH and effectively switches the
enzyme specificity toward NADH (28). Conservation of this
lysine among type I Baeyer–Villiger monooxygenases (Fig. 2)
agrees with the strict NADPH specificity observed for members
of this enzyme family (2).
Analysis of the stereospecificity in 4-hydroxyacetophenone
monooxygenase (unpublished data) shows that the reaction
involves the transfer of the pro-R hydrogen from the nicotin-
amide to the flavin. This stereospecificity is opposite to that of
the disulfide oxidoreductases (31), implying that, compared with
the binding mode observed in these enzymes, the nicotinamide
ring bound to PAMO and similar monooxygenases has a flipped
orientation with respect to the flavin. A detailed analysis of the
NADPH-binding mode must await the crystal structure deter-
mination of a protein complex.
The Central Role of Arg-337. Arg-337 is a strictly conserved amino
acid among Baeyer–Villiger monooxygenases (Fig. 2), and the
crystal structure now shows that it is part of the active site,
located on the re side of the flavin. In 4-hydroxyacetophenone
monooxygenase, mutation of the corresponding Arg residue to
Ala makes the enzyme completely inactive (28). The mutation
does not affect binding of NADPH nor flavin reduction by
NADPH (Fig. 1), but it completely knocks out the ability to
catalyze the insertion of the oxygen atom into the substrate. This
finding suggested that this Arg residue stabilizes the negatively
charged flavin-peroxide intermediate (28). The crystal structure
fully supports this conclusion by showing that Arg-337 is in front
of flavin C4a atom, the locus where the peroxide adduct is
formed (Fig. 1). In both conformations found in the crystal
structure, the Arg-337 side chain would appear to be able to
directly interact with the intermediate, possibly forming direct
H-bonds (Fig. 6).
The conformation and position of Arg-337 suggests an even
more complex role in catalysis than simply intermediate stabi-
lization. In the crystal structure, Arg-337 is not fixed in a single
conformation, but it adopts two alternate conformations (Fig. 5).
This feature underlies an inherent flexibility that can be func-
tionally relevant. Reduction of the flavin by NADPH involves
the direct transfer of a hydride anion from the nicotinamide ring
to the N5 atom of the cofactor. As indicated by the three-
dimensional structures of many flavoenzymes (24), hydride
transfer is brought about by positioning the nicotinamide adja-
cent to the flavin so that the two rings overlap each other. In the
case of PAMO, this process must necessarily involve a movement
of the Arg-337 side chain, which must shift away from the
Fig. 3. Ribbon diagram of the PAMO monomer. The FAD-binding domain
(residues 10–158 and 390–542) is shown in green, and the NADP-binding
domain (159–389) is shown in blue. Residues 220–340, which form a subdo-
main inserted into the canonical NADP-binding domain topology, are de-
picted in cyan. The C-terminal helical extension (residues 475–542) found in
the dinucleotide-binding fold of the FAD domain is labeled. The fingerprint
residues (167–177), which characterize the Baeyer–Villiger monooxygenases
(27), are outlined in red. His-173 is a strictly conserved residue of the finger-
print motif that has been shown to be crucial for catalysis. The N-terminal and
C-terminal residues are labeled by N and C, respectively. The FAD cofactor and
bound sulfate ion are shown in yellow and black ball-and-stick representa-
tions, respectively.
Fig. 4. Stereo view of the flavin-binding site. The orientation is approximately the same as that of Fig. 3. The flavin has a planar conformation although its
N10 atom exhibits a considerable degree of pyramidalization, which positions the C1 atom of the ribityl chain out of the flavin plane. Carbons are shown in black,
oxygens are shown in red, and nitrogens are shown in blue. Ordered water molecules are shown as red spheres. H-bond interactions are outlined by the dashed
lines.
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position observed in the crystal structure to allow the binding of
nicotinamide with the catalytically competent stereochemistry.
Arg-337 is predicted to exist in two positions: (i) an ‘‘IN’’
position, corresponding to that found in the crystal structure and
involved in the stabilization of the flavin-peroxide intermediate
during catalysis and (ii) an ‘‘OUT’’ position, which provides the
space for the nicotinamide ring to perform cofactor reduction.
Support for drastic changes in the flavin environment occurring
during catalysis is provided by analysis of cyclohexanone mono-
oxygenase, which exhibits extraordinarily large spectral changes
upon NADP binding (7).
Conformational Changes in Catalysis. The two-domain architecture
of PAMO suggests that the catalytically relevant conformational
changes might be brought about partly by a movement of the
NADP-binding domain. The intriguing feature of this idea is that a
domain rotation would couple the ‘‘moving INOUT’’ of the
NADP nicotinamide ring with the moving OUTIN of the Arg-337
side chain, which also belongs to the NADP-binding domain (Fig.
6). The comparison of the PAMO structure with those of
NAD(P)H complexes of disulfide oxidoreductases (25, 29, 30)
shows that the NADP-binding domain of PAMO adopts a generally
more open conformation with respect to that of the topologically
similar proteins. Domain movements are not unprecedented in
proteins with this domain topology; for instance, a 67° rotation of
the NADPH domain has been shown to occur during catalysis of
thioredoxin reductase (30). The domain linker of PAMO comprises
two antiparallel -strands (residues 158–160 and 387–389) (Fig. 3),
which are highly conserved in amino acid sequence among Baeyer–
Villiger monooxygenases (Fig. 2). This ‘‘double-hinge’’ -sheet
construction is similar to that of the domain linker of thioredoxin
reductase, and it has been found at the hinge points in several
proteins that exhibit domain motions (32).
The amino acid sequences of the Baeyer–Villiger monooxy-
genases are characterized by the conserved sequence motif
FXGXXXHXXXW (27), which in PAMO corresponds to res-
idues 167–177 (Figs. 2, 3, and 6). Most remarkably, the three-
dimensional structure shows that the fingerprint amino acids
belong to the linker segment that connects the FAD-binding
domain to the NADP-binding domain and are not directly part
of the active site. Mutagenesis studies have shown that the strictly
conserved His residue belonging to the fingerprint sequence
(His-173 in PAMO) is crucial for catalysis and FAD binding. In
cyclohexanone monooxygenase (33), the replacement of this His
residue with Gln causes a 10-fold reduction in activity, whereas
in 4-hydroxyacetophenone monooxygenase (27), the His3Ala
mutation makes the enzyme inactive. In the crystal structure,
His-173 is fully solvent exposed being part of the domain linker
region at 16 Å from the flavin and at 10 Å from the
NADP-binding site (Figs. 3 and 6). Rather than being directly
involved in substrate binding and catalysis, His-173 and the
fingerprint motif residues are likely to have a critical role by
taking part in the domain rotations and conformational changes
that occur during the catalytic cycle.
A Model for Catalysis. The crystallographic analysis provides a
structural framework for the mechanism of the catalytic reaction
proposed on the bases of the kinetic data (7, 28, 33) measured
on several Baeyer–Villiger monooxygenases (Figs. 1 and 7).
1. The reaction starts with the binding of NADPH, which is in
the proper position to perform flavin reduction. Simulta-
neously, Arg-337 adopts the OUT position.
Fig. 5. Stereo view of the final 2Fo  Fc electron density map for the flavin and Arg-337 in approximately the same orientation as in Fig. 3. The contour level
is 1 . Atom colors are as in Fig. 4.
Fig. 6. Close-up view of the NADP-binding site at the domain interface. The
FAD cofactor is shown in yellow. Ribbons are colored as in Fig. 3. The picture
shows the position of residues that have been shown to be crucial for catalysis
andor NADPH binding. A NADPH molecule is shown modeled in the confor-
mation observed in topologically similar enzymes (black). The image was
generated by superimposing the NADP-binding domain of human glutathi-
one reductase in complex with NADPH (29) to the corresponding domain of
PAMO. The resulting position of the NADPH molecule bound to glutathione
reductase is depicted. As a reference, a model for the peroxide adduct is shown
in black. The adduct has been modeled based on the three-dimensional
structure of 4a,5-epoxyethano-3-methyl-4a,5-dihydrolumiflavin (38).








2. The reduced enzyme reacts with oxygen to form the flavin-
peroxide intermediate. This step requires a conformational
change, possibly involving a domain rotation coupled to a
conformational change of Arg-337 and neighboring residues,
which would bring the Arg-337 side chain in proximity of the
flavin (IN position) to stabilize the negatively charged
peroxide intermediate.
3. The substrate binds and is oxygenated by the flavin. Arg-337
might be involved in the stabilization of the tetrahedral
Criegee intermediate formed by the attack of the flavin-
OO group onto the substrate. As suggested by the kinetic
analysis of cyclohexanone monooxygenase (7), NADP re-
mains bound to the NADP-binding domain, which is ex-
pected to be in an open conformation similar to that present
in the crystal structure. NADP bound to this domain
conformation does not block accessibility to the active site
(Fig. 6).
4. The enzyme ternary complex (E:NADP:product) dissoci-
ates, and the products are released.
This initial model for enzyme catalysis needs to be validated and
understood in more detail by future studies.
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